company background image
SCIE logo

SpectraScience OTCPK:SCIE Stock Report

Last Price

US$0.000001

Market Cap

US$5.0k

7D

0%

1Y

-99.0%

Updated

28 Mar, 2024

Data

Company Financials

SCIE Stock Overview

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally.

SCIE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

SpectraScience, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SpectraScience
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Change0%
1 Year Change-99.00%
3 Year Change-99.60%
5 Year Change0%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

SCIEUS Medical EquipmentUS Market
7D0%2.2%0.4%
1Y-99.0%13.3%28.8%

Return vs Industry: SCIE underperformed the US Medical Equipment industry which returned 13.3% over the past year.

Return vs Market: SCIE underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is SCIE's price volatile compared to industry and market?
SCIE volatility
SCIE Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: SCIE has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SCIE's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1983n/aMike Oliverhttps://www.spectrascience.com

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps.

SpectraScience, Inc. Fundamentals Summary

How do SpectraScience's earnings and revenue compare to its market cap?
SCIE fundamental statistics
Market capUS$4.97k
Earnings (TTM)-US$5.35m
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SCIE income statement (TTM)
RevenueUS$0
Cost of RevenueUS$196.44k
Gross Profit-US$196.44k
Other ExpensesUS$5.15m
Earnings-US$5.35m

Last Reported Earnings

Sep 30, 2017

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did SCIE perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.